The KEGG pathway enrichment showed that Tau-interacting proteins were specifically associated with neurological diseases, such as Parkinson disease, Alzheimer disease, and Huntington disease (Table 3). The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.